Ionis Pharmaceuticals
Utility Patents
Last updated:
List of all Ionis Pharmaceuticals patents 91 in total
| Status | Patent |
|---|---|
Grant | Utility: Compounds and methods for modulating angiotensinogen expression Filling date: 8 Sep 2025 Issue date: 20 Sep 2022 |
Grant | Utility: Compounds and methods for reducing ATXN3 expression Filling date: 8 Sep 2025 Issue date: 6 Sep 2022 |
Grant | Utility: Modulation of Huntington expression Filling date: 8 Sep 2025 Issue date: 23 Aug 2022 |
Grant | Utility: Modified CRISPR RNA and modified single CRISPR RNA and uses thereof Filling date: 8 Sep 2025 Issue date: 16 Aug 2022 |
Grant | Utility: Method of conjugating oligomeric compounds Filling date: 8 Sep 2025 Issue date: 2 Aug 2022 |
Grant | Utility: Modulation of factor 11 expression Filling date: 8 Sep 2025 Issue date: 5 Jul 2022 |
Grant | Utility: Modulators of EZH2 expression Filling date: 8 Sep 2025 Issue date: 21 Jun 2022 |
Grant | Utility: Compositions for modulating C9ORF72 expression Filling date: 8 Sep 2025 Issue date: 24 May 2022 |
Grant | Utility: Compounds and methods for reducing LRRK2 expression Filling date: 8 Sep 2025 Issue date: 17 May 2022 |
Grant | Utility: Modified compounds and uses thereof Filling date: 8 Sep 2025 Issue date: 17 May 2022 |
Grant | Utility: Modulating apolipoprotein (a) expression Filling date: 8 Sep 2025 Issue date: 3 May 2022 |
Grant | Utility: Compositions and methods for modulating growth hormone receptor expression Filling date: 8 Sep 2025 Issue date: 26 Apr 2022 |
Grant | Utility: Conjugated antisense compounds and their use Filling date: 8 Sep 2025 Issue date: 12 Apr 2022 |
Grant | Utility: Compositions and methods for modulating Ataxin 3 expression Filling date: 8 Sep 2025 Issue date: 5 Apr 2022 |
Grant | Utility: Modulators of MALAT1 expression Filling date: 8 Sep 2025 Issue date: 22 Mar 2022 |
Grant | Utility: Selective antisense compounds and uses thereof Filling date: 8 Sep 2025 Issue date: 1 Feb 2022 |
Grant | Utility: Antisense compounds and uses thereof Filling date: 8 Sep 2025 Issue date: 1 Feb 2022 |
Grant | Utility: Compounds and methods for reducing SNCA expression Filling date: 8 Sep 2025 Issue date: 25 Jan 2022 |
Grant | Utility: Modulation of angiopoietin-like 3 expression Filling date: 8 Sep 2025 Issue date: 18 Jan 2022 |
Grant | Utility: Modulators of IRF5 expression Filling date: 8 Sep 2025 Issue date: 28 Dec 2021 |
Grant | Utility: Compositions for modulating expression of C9ORF72 antisense transcript Filling date: 8 Sep 2025 Issue date: 7 Dec 2021 |
Grant | Utility: Methods for modulating expression of C9ORF72 antisense transcript Filling date: 8 Sep 2025 Issue date: 2 Nov 2021 |
Grant | Utility: Modified compounds and uses thereof Filling date: 8 Sep 2025 Issue date: 19 Oct 2021 |
Grant | Utility: Methods and compositions for inhibiting PMP22 expression Filling date: 8 Sep 2025 Issue date: 5 Oct 2021 |
Grant | Utility: Compositions and methods for modulating MECP2 expression Filling date: 8 Sep 2025 Issue date: 28 Sep 2021 |
Grant | Utility: Oligomer-conjugate complexes and their use Filling date: 8 Sep 2025 Issue date: 31 Aug 2021 |
Grant | Utility: Compositions and methods for modulation of IKBKAP splicing Filling date: 8 Sep 2025 Issue date: 20 Jul 2021 |
Grant | Utility: Methods of treating breast cancer Filling date: 8 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: Modulation of prekallikrein (PKK) expression Filling date: 8 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: Modulation of Lnc05 expression Filling date: 8 Sep 2025 Issue date: 15 Jun 2021 |
Grant | Utility: Compounds and methods for reducing FXI expression Filling date: 8 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: Allele specific modulators of P23H rhodopsin Filling date: 8 Sep 2025 Issue date: 25 May 2021 |
Grant | Utility: Modulators of PCSK9 expression Filling date: 8 Sep 2025 Issue date: 11 May 2021 |
Grant | Utility: Methods of modulating KEAP1 Filling date: 8 Sep 2025 Issue date: 30 Mar 2021 |
Grant | Utility: Compounds and methods for modulation of dystrophia myotonica-protein kinase (DMPK) expression Filling date: 8 Sep 2025 Issue date: 23 Mar 2021 |
Grant | Utility: Modulation of androgen receptor expression Filling date: 8 Sep 2025 Issue date: 9 Mar 2021 |
Grant | Utility: Modulators of APOL1 expression Filling date: 8 Sep 2025 Issue date: 23 Feb 2021 |
Grant | Utility: Compositions and methods for modulating apolipoprotein C-III expression Filling date: 8 Sep 2025 Issue date: 23 Feb 2021 |
Grant | Utility: Compounds and methods for modulating angiotensinogen expression Filling date: 8 Sep 2025 Issue date: 9 Feb 2021 |
Grant | Utility: Methods for reducing LRRK2 expression Filling date: 8 Sep 2025 Issue date: 2 Feb 2021 |
Grant | Utility: Compositions and methods for modulating apolipoprotein (a) expression Filling date: 8 Sep 2025 Issue date: 5 Jan 2021 |
Grant | Utility: Compositions and methods for modulating angiopoietin-like 3 expression Filling date: 8 Sep 2025 Issue date: 29 Dec 2020 |
Grant | Utility: Modulators of DNM2 expression Filling date: 8 Sep 2025 Issue date: 15 Dec 2020 |
Grant | Utility: Oligomeric compounds comprising .alpha.-.beta.-constrained nucleic acid Filling date: 8 Sep 2025 Issue date: 15 Dec 2020 |
Grant | Utility: Methods for treating hypercholesterolemia Filling date: 8 Sep 2025 Issue date: 8 Dec 2020 |
Grant | Utility: Modulation of SMN expression Filling date: 8 Sep 2025 Issue date: 1 Dec 2020 |
Grant | Utility: Conjugated antisense compounds and their use Filling date: 8 Sep 2025 Issue date: 24 Nov 2020 |
Grant | Utility: Modulation of huntingtin expression Filling date: 8 Sep 2025 Issue date: 17 Nov 2020 |
Grant | Utility: Compounds and methods for the modulation of proteins Filling date: 8 Sep 2025 Issue date: 3 Nov 2020 |
Grant | Utility: Compositions for modulating C9ORF72 expression Filling date: 8 Sep 2025 Issue date: 27 Oct 2020 |
Showing 1 to 50 of 91 patents.